Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod201

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod201
Module size 84 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
132949

AASDH aminoadipate-semialdehyde dehydrogenase
641372

ACOT6 acyl-CoA thioesterase 6
55

ACPP acid phosphatase, prostate
93650

ACPT acid phosphatase 4
54936

ADPRHL2 ADP-ribosylhydrolase like 2
309

ANXA6 annexin A6
8623

ASMTL acetylserotonin O-methyltransferase like
683

BST1 bone marrow stromal cell antigen 1
297767

BTD recombination signal binding protein for immunoglobulin kappa J region-like 2
84520

C14orf142 GON7, KEOPS complex subunit
79078

C1orf50 chromosome 1 open reading frame 50
813

CALU calumenin
952

CD38 CD38 molecule
25927

CNRIP1 cannabinoid receptor interacting protein 1
80347

COASY Coenzyme A synthase
118881

COMTD1 catechol-O-methyltransferase domain containing 1
25927

CRIP1 cannabinoid receptor interacting protein 1
79877

DCAKD dephospho-CoA kinase domain containing
1635

DCTD dCMP deaminase
112487

DTD2 D-tyrosyl-tRNA deacylase 2 (putative)
285605

DTWD2 DTW domain containing 2
1841

DTYMK deoxythymidylate kinase
84332

DYDC2 DPY30 domain containing 2
80820

EEPD1 endonuclease/exonuclease/phosphatase family domain containing 1
55531

ELMOD1 ELMO domain containing 1
5167

ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1
5169

ENPP3 ectonucleotide pyrophosphatase/phosphodiesterase 3
57089

ENTPD7 ectonucleoside triphosphate diphosphohydrolase 7
80308

FLAD1 flavin adenine dinucleotide synthetase 1
2643

GCH1 GTP cyclohydrolase 1
9615

GDA guanine deaminase
2987

GUK1 guanylate kinase 1
374659

HDDC3 HD domain containing 3
727833

IMPDH1 inosine monophosphate dehydrogenase 1 pseudogene 11
3615

IMPDH2 inosine monophosphate dehydrogenase 2
65987

KCTD14 potassium channel tetramerization domain containing 14
26128

KIAA1279 KIF1 binding protein
220074

LRTOMT leucine rich transmembrane and O-methyltransferase domain containing
57149

LYRM1 LYR motif containing 1
4507

MTAP methylthioadenosine phosphorylase
65220

NADK NAD kinase
55191

NADSYN1 NAD synthetase 1
10135

NAMPT nicotinamide phosphoribosyltransferase
NA

NAMPTL
93100

NAPRT1 nicotinate phosphoribosyltransferase
60491

NIF3L1 NGG1 interacting factor 3 like 1
64802

NMNAT1 nicotinamide nucleotide adenylyltransferase 1
23057

NMNAT2 nicotinamide nucleotide adenylyltransferase 2
349565

NMNAT3 nicotinamide nucleotide adenylyltransferase 3
4837

NNMT nicotinamide N-methyltransferase
23530

NNT nicotinamide nucleotide transhydrogenase
51559

NT5DC3 5'-nucleotidase domain containing 3
4521

NUDT1 nudix hydrolase 1
83594

NUDT12 nudix hydrolase 12
256281

NUDT14 nudix hydrolase 14
55270

NUDT15 nudix hydrolase 15
79873

NUDT18 nudix hydrolase 18
114299

PALM2 paralemmin 2
79646

PANK3 pantothenate kinase 3
55229

PANK4 pantothenate kinase 4
5099

PCDH7 protocadherin 7
57026

PDXP pyridoxal phosphatase
56952

PRTFDC1 phosphoribosyl transferase domain containing 1
58497

PRUNE prune exopolyphosphatase 1
23475

QPRT quinolinate phosphoribosyltransferase
115286

SLC25A26 solute carrier family 25 member 26
54974

THG1L tRNA-histidine guanylyltransferase 1 like
643853

TMPPE transmembrane protein with metallophosphoesterase domain
112858

TP53RK TP53 regulating kinase
293894

TPD52 tumor protein D52-like 3
7165

TPD52L2 TPD52 like 2
89882

TPD52L3 TPD52 like 3
289159

TPMT methyltransferase like 13
51002

TPRKB TP53RK binding protein
83707

TRPT1 tRNA phosphotransferase 1
83549

UCK1 uridine-cytidine kinase 1
54963

UCKL1 uridine-cytidine kinase 1 like 1
139596

UPRT uracil phosphoribosyltransferase homolog
8876

VNN1 vanin 1
8875

VNN2 vanin 2
55350

VNN3 vanin 3
55093

WDYHV1 WDYHV motif containing 1
7498

XDH xanthine dehydrogenase
57002

YAE1D1 YAE1, ABCE1 maturation factor

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
2.58e-01 9.29e-09 GO nucleoside-triphosphate diphosphatase activity

molecular_function
2.12e-01 2.70e-07 GO nicotinate-nucleotide adenylyltransferase activity

molecular_function
2.06e-01 6.73e-07 GO pantothenate metabolic process

biological_process
1.97e-01 7.11e-16 GO NAD metabolic process

biological_process
1.45e-01 2.86e-13 Reactome Vitamin B5 (pantothenate) metabolism

Metabolism
1.34e-01 2.12e-19 Reactome Nicotinate metabolism

Metabolism
1.28e-01 2.34e-06 Reactome Phosphate bond hydrolysis by NUDT proteins

Metabolism
1.21e-01 8.25e-03 Reactome Synthesis of dolichyl-phosphate-glucose

Metabolism of proteins
1.11e-01 2.50e-04 GO EKC/KEOPS complex

cellular_component
7.68e-02 8.65e-08 GO coenzyme A biosynthetic process

biological_process
4.89e-02 1.74e-16 Reactome Metabolism of nucleotides

Metabolism
2.66e-02 4.64e-04 GO O-methyltransferase activity

molecular_function
2.38e-02 1.86e-07 GO purine nucleotide catabolic process

biological_process
1.95e-02 1.24e-02 Reactome Enzymatic degradation of dopamine by COMT

Neuronal System
1.74e-02 4.18e-27 Reactome Metabolism of water-soluble vitamins and cofactors

Metabolism
1.04e-02 3.49e-04 Reactome Vitamin B2 (riboflavin) metabolism

Metabolism
2.81e-04 3.53e-07 GO nucleobase-containing small molecule catabolic process

biological_process

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
0.00e+00 0.00e+00 nucleobase-containing small molecule metabolic process

0.00e+00 0.00e+00 nucleotide biosynthetic process

0.00e+00 0.00e+00 nucleoside metabolic process

0.00e+00 0.00e+00 nucleotide metabolic process

0.00e+00 0.00e+00 cofactor metabolic process

0.00e+00 0.00e+00 NAD biosynthetic process

0.00e+00 0.00e+00 NAD metabolic process

0.00e+00 0.00e+00 nucleoside phosphate catabolic process

0.00e+00 0.00e+00 organophosphate catabolic process

3.07e-17 2.91e-14 coenzyme biosynthetic process

9.90e-13 9.17e-10 purine nucleotide metabolic process

1.71e-11 1.52e-08 ribonucleotide metabolic process

6.24e-11 5.29e-08 glycosyl compound metabolic process

2.29e-09 1.15e-06 nucleoside-triphosphate diphosphatase activity

2.53e-09 1.79e-06 ribose phosphate biosynthetic process

7.42e-09 4.90e-06 nucleotide catabolic process

1.06e-08 4.81e-06 NADH pyrophosphatase activity

2.88e-08 1.76e-05 purine nucleoside metabolic process

3.03e-08 1.85e-05 purine-containing compound biosynthetic process

3.42e-08 1.42e-05 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
0.00e+00 0.00e+00 METABOLISM OF VITAMINS AND COFACTORS
0.00e+00 0.00e+00 METABOLISM OF VITAMINS AND COFACTORS
1.67e-09 5.37e-07 METABOLISM OF NUCLEOTIDES
1.03e-08 2.26e-06 METABOLISM OF NUCLEOTIDES
1.82e-05 3.31e-03 PURINE METABOLISM
3.54e-05 4.86e-03 PURINE METABOLISM
6.11e-05 8.08e-03 VITAMIN B5 PANTOTHENATE METABOLISM
8.21e-05 1.30e-02 VITAMIN B5 PANTOTHENATE METABOLISM
1.83e-04 2.65e-02 PURINE CATABOLISM
6.03e-04 6.40e-02 PURINE CATABOLISM
1.62e-03 1.78e-01 PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
2.86e-03 2.54e-01 PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
3.77e-03 3.62e-01 PYRIMIDINE METABOLISM
5.19e-03 4.71e-01 SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
7.89e-03 6.04e-01 SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
8.74e-03 6.58e-01 PYRIMIDINE METABOLISM
1.87e-02 1.00e+00 PHASE II CONJUGATION
2.58e-02 1.00e+00 ABACAVIR TRANSPORT AND METABOLISM
3.16e-02 1.00e+00 ABACAVIR TRANSPORT AND METABOLISM
3.65e-02 1.00e+00 TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
6.17e-04 6.83e-01 hunched posture

1.14e-03 9.71e-01 absent startle reflex

3.17e-03 1.00e+00 decreased bone mass

3.76e-03 1.00e+00 calcified retina

3.77e-03 1.00e+00 organ of Corti degeneration

3.85e-03 1.00e+00 abnormal behavior

5.61e-03 1.00e+00 cochlear ganglion degeneration

5.63e-03 1.00e+00 calcified skin

6.58e-03 1.00e+00 abnormal kidney development

7.48e-03 1.00e+00 absent optic tract

7.49e-03 1.00e+00 decreased corticospinal tract size

7.49e-03 1.00e+00 abnormal skin adnexa morphology

7.51e-03 1.00e+00 calcified aorta

7.52e-03 1.00e+00 calcified intervertebral disk

7.52e-03 1.00e+00 calcified joint

9.33e-03 1.00e+00 decreased circulating glucose level

9.37e-03 1.00e+00 abnormal ligament morphology

9.38e-03 1.00e+00 abnormal urethra morphology

9.38e-03 1.00e+00 exostosis

1.12e-02 1.00e+00 calcinosis


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:29:44 2018 - R2HTML